Takeda Pharmaceutical (TAK) EBITDA Margin Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.60 Bn | 42.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.36 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 12.04 Bn | 11.51 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.07 Bn | 9.90 Bn | - | - |
| 10 | Alkermes | 8.23 Bn | 7.57 Bn | 397.90 Mn | -2,010.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.00 |
| Mar 31, 2026 | 123.00 |
| Dec 31, 2025 | -3,092.00 |
| Sep 30, 2025 | 14.00 |
| Jun 30, 2025 | 291.00 |
| Mar 31, 2025 | 132.00 |
| Dec 31, 2024 | -1,554.00 |
| Sep 30, 2024 | -68.00 |
| Jun 30, 2024 | -215.00 |
| Mar 31, 2024 | -197.00 |
| Dec 31, 2023 | -497.00 |
| Sep 30, 2023 | 209.00 |
| Jun 30, 2023 | 45.00 |
| Mar 31, 2023 | -964.00 |
| Dec 31, 2022 | 48.00 |
| Sep 30, 2022 | -111.00 |
| Jun 30, 2022 | -1,070.00 |
| Mar 31, 2022 | 602.00 |
| Dec 31, 2021 | -418.00 |
| Sep 30, 2021 | 541.00 |